{
  "retracted": false,
  "timestamp": 1550102400000,
  "updates": [
    {
      "timestamp": 1574879839162,
      "identifier": {
        "doi": "10.1182/blood-2019-01-895136"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1182/blood-2017-10-810739"
  },
  "journal": "Blood",
  "publisher": "American Society of Hematology",
  "title": "Porpaczy E, Tripolt S, Hoelbl-Kovacic A, et al. Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy. Blood. 2018;132(7):694-706."
}
